24.03.2016 • News

Safic-Alcan Acquires 100% of Interplast

France-based international distributor Safic-Alcan has completed the acquisition of 100% of Turkish distributor Interplast after acquiring a majority shareholding in 2011.

The company said Interplast’s general manager Ayhan Güler will remain in the position and will continue to actively manage the business.

Founded in 2004, the Turkish distributor, which has annual sales of  €21 million, employs 30 people and serves 50 different suppliers from 20 different countries, “has developed an outstanding reputation in the distribution of technically superior quality of thermoplastics, rubber, coatings, adhesives, cosmetics, personal care and pharmaceuticals,” Safic-Alcan said.

“Gaining full ownership of Interplast is part of our growth strategy. We are still exploring other acquisitions to strengthen our competitive advantage not only in Turkey but also in the neighboring areas such as the Balkans, the Middle East, the Caucasus, Central Asia and North Africa,” said Martial Lecat, CEO of Safinca, the holding company of Safic-Alcan Group.

In other news, Safic-Alcan has signed an agreement with Arkema subsidiary Coatex to distribute the South Carolina, USA-based company’s Rheosty products, a range of specialty rheology modifiers for cosmetics applications. The contract covers France, Italy, Germany, Benelux, Switzerland, Poland, Slovakia, Austria, Hungary, Czech Republic and Turkey.

Coatex said the partnership with Safic-Alcan is “a decisive milestone” in its strategy to innovate and expand on the personal care market.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.